Literature DB >> 7248820

Effect of 4-aminopyridine on cardiovascular functions in the dog.

E Martínez-Aguirre, J A Wikinski, A Bello, J Izquierdo, A Garcia, H Velarde.   

Abstract

The drug 4-aminopyridine (4-AP) at a dose of 0.2 mg . kg-1 body weight intravenously is an effective antagonist of non-depolarizing neuromuscular blockade. We studied its cardiovascular effects in the canine heart using a right-heart bypass with extracorporeal circulation in seven dogs. This study demonstrates that 4-aminopyridine significantly augments arterial blood pressure, left ventricular dp/dt maximum, as well as left ventricular pressure at dp/dt mx. The highest values were obtained between two and 20 minutes after administration of 4-AP. Left ventricular end-diastolic pressure diminished slightly, but this was not statistically significant. Although the exact mechanism of action of 4-AP is not known, its positive inotropic effects may be of value in the reversal of non-depolarizing neuromuscular blockade in patients with impaired myocardial function of diverse aetiologies and it would be contra-indicated in patients with arterial hypertension and/or coronary artery disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7248820     DOI: 10.1007/bf03007253

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  17 in total

1.  The mode of action of 4-aminopyridine and guanidine on transmitter release from motor nerve terminals.

Authors:  H Lundh; S Thesleff
Journal:  Eur J Pharmacol       Date:  1977-04-21       Impact factor: 4.432

2.  Antagonism of polymyxin B-induced neuromuscular and cardiovascular depression by 4-aminopyridine in the anesthetized cat.

Authors:  C Lee; A J de Silva; R L Katz
Journal:  Anesthesiology       Date:  1978-10       Impact factor: 7.892

3.  Aminopyridines and sparteine as inhibitors of membrane potassium conductance: effects on Myxicola giant axons and the lobster neuromuscular junction.

Authors:  C L Schauf; C A Colton; J S Colton; F A Davis
Journal:  J Pharmacol Exp Ther       Date:  1976-05       Impact factor: 4.030

4.  Proceedings: Selective inhibition of potassium current in the giant axon of the cockroach.

Authors:  M Pelhate; Y Pichon
Journal:  J Physiol       Date:  1974-10       Impact factor: 5.182

5.  [On the anticurare action of aminopyridines].

Authors:  M Lemeignan; P Lechat
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1967-01-04

6.  [New anti-curare and analeptic drug, Pimadin, and its use in anesthesia].

Authors:  D S Paskov; N A Stoianov; V Z Mitsov
Journal:  Eksp Khir Anesteziol       Date:  1973 Jul-Aug

Review 7.  Chemicals as tools in the study of excitable membranes.

Authors:  T Narahashi
Journal:  Physiol Rev       Date:  1974-10       Impact factor: 37.312

8.  Effects of ketamine on canine cardiovascular function.

Authors:  F A Diaz; J A Bianco; A Bello; N Beer; H Velarde; J P Izquierdo; R Jaen
Journal:  Br J Anaesth       Date:  1976-10       Impact factor: 9.166

9.  Spontaneous and evoked activity of motor nerve endings in calcium Ringer.

Authors:  B Katz; R Miledi
Journal:  J Physiol       Date:  1969-08       Impact factor: 5.182

10.  Neostigmine and 4-aminopyridine antagonism of lincomycin-pancuronium neuromuscular blockade in man.

Authors:  L H Booij; R D Miller; J F Crul
Journal:  Anesth Analg       Date:  1978 May-Jun       Impact factor: 5.108

View more
  2 in total

1.  Failure of 4-aminopyridine positive inotropic effect.

Authors:  E Martínez-Aguirre; J A Wikinski
Journal:  Can Anaesth Soc J       Date:  1982-01

2.  Antagonism of d-tubocurarine-induced neuromuscular blockade with a mixture of 4-aminopyridine and neostigmine in man.

Authors:  K Wirtavuori; M Salmenperä; T Tammisto
Journal:  Can Anaesth Soc J       Date:  1984-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.